BioLife Solutions Akcie

BioLife Solutions EBITDA

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti BioLife Solutions (BLFS) k datu 13. 8. 2026 je -818 000,00 USD. V předchozím roce byl EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) -6,87 Mil. USD — změna o -88,09 % (vyšší).

EBITDA

-818 000,00USD

YoY

-88,09%

Poslední aktualizace:

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti BioLife Solutions je 2026 -818 000,00 USD. EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti BioLife Solutions byl 2025 -6,87 Mil. USD. Klesá tak o -88,09% vyšší než v předchozím roce.
Access this data via the Eulerpool API

BioLife Solutions Analýza akcií

Co dělá BioLife Solutions? BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry. BioLife Solutions je jednou z nejoblíbenějších společností na Eulerpool.com.

Často kladené otázky ohledně akcií BioLife Solutions

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti BioLife Solutions činí -818 000,00 USD v roce 2026.

EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) společnosti BioLife Solutions se změnilo z -6,87 Mil. USD na -818 000,00 USD, což představuje změnu o -88,09 %. Hodnota je vyšší než v předchozím roce.

Na Eulerpool najdete úplný historický vývoj EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) BioLife Solutions od roku 2006 – s ročními hodnotami, grafy a podrobnou analýzou.

EBITDA měří operační výkonnost před dopadem finanční struktury, daňového prostředí a bezhotovostních odpisů.

EBITDA = EBIT + Odpisy

USD společnosti EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) je důležitým faktorem pro investory. Změny v tomto ukazateli mohou signalizovat zlepšování nebo zhoršování fundamentů, což může ovlivnit cenu akcie. Na Eulerpool můžete sledovat BioLife Solutions společnosti EBITDA (Zisk před úroky, daněmi, odpisy a amortizací) historicky.

Access this data via the Eulerpool API

Výkaz zisku a ztráty — BioLife Solutions

Všechny klíčové ukazatele — BioLife Solutions